Skip to content

Do 503A Compounding Pharmacies Need Validated Software?

503A compounding pharmacy technician preparing medication
If you operate a 503A compounding pharmacy, you may not be required to use validated software in the same way as a pharmaceutical manufacturer or a 503B outsourcing facility. But that does not necessarily mean that non-validated software is the better choice.When validated software is available at a similar cost, is straightforward to implement, and does not require a large validation effort to maintain, it can provide an additional level of control and documentation without creating the burden that many smaller organizations associate with pharmaceutical computerized systems. Understanding why starts with the difference between 503A, 503B, and traditional pharmaceutical manufacturing.

What Is a 503A Compounding Pharmacy?

Section 503A of the Federal Food, Drug, and Cosmetic Act applies primarily to traditional pharmacy compounding performed by licensed pharmacists in state-licensed pharmacies or federal facilities, or by licensed physicians. When the requirements of Section 503A are met, compounded drug products may qualify for exemptions from several provisions of federal drug law, including the current Good Manufacturing Practice, or CGMP, requirements that apply to conventional pharmaceutical manufacturers. FDA explains the applicable requirements for 503A and 503B compounders in its overview of FD&C Act provisions that apply to human drug compounding . This is an important distinction. A 503A pharmacy is not simply a smaller pharmaceutical manufacturing facility operating under the same regulatory framework. 503A compounding generally centers on patient-specific prescriptions and remains subject to other applicable federal requirements as well as state pharmacy laws and standards.

How Is 503B Different?

Section 503B created a separate category known as an outsourcing facility. Unlike compounders operating under Section 503A, 503B outsourcing facilities are subject to CGMP requirements. They are also registered with FDA, inspected according to a risk-based schedule, and subject to additional requirements such as product reporting and adverse-event reporting. A 503B facility may also compound products without first receiving a patient-specific prescription, such as products intended for office stock. FDA provides additional information on these requirements in its Human Drug Compounding Laws resource.

503A, 503B, and Conventional Pharmaceutical Manufacturing

  • 503A: May qualify for exemption from federal CGMP requirements when all applicable conditions of Section 503A are met.
  • 503B: Subject to CGMP requirements.
  • Conventional pharmaceutical manufacturing: Subject to the applicable CGMP requirements for drug manufacturing.
That difference matters when computerized systems are selected and controlled.

Does That Mean a 503A Pharmacy Does Not Need Validated Software?

Not necessarily. The fact that a 503A pharmacy may qualify for exemption from CGMP requirements does not mean that software used to support important operations should be uncontrolled or unreliable. Consider computerized systems used to manage activities such as:
  • Equipment calibration
  • Preventive maintenance
  • Equipment qualification
  • Facility and equipment records
  • Controlled equipment histories
  • User access
  • Changes to critical records
For these applications, the practical question may be less:
“Am I explicitly required to validate this software?”
and more:
“How do I know this system reliably performs the functions I depend on?”
That is the basic purpose of software validation: documented evidence that a computerized system performs its intended functions appropriately and consistently for its intended use.

Why Smaller Facilities Often Avoid Validated Systems

The term validated software can sound expensive and complicated. For organizations familiar with large pharmaceutical implementations, validation may bring to mind:
  • Detailed requirements specifications
  • Multiple validation protocols
  • Extensive change control
  • Outside consultants
  • Months of implementation work
  • Large IT departments
  • Expensive enterprise software
For a smaller compounding pharmacy, that level of infrastructure may make little practical or economic sense. But validated software does not inherently require that level of overhead. The amount of validation effort should be appropriate to the complexity, intended use, and risk of the system.

A More Practical Approach to Validated Software

For relatively straightforward applications such as equipment calibration, maintenance, and qualification tracking, the system itself does not have to be particularly complicated. That creates an opportunity to obtain many of the benefits of a controlled, validated system without creating an enterprise-scale validation program. GxPReady Suite™ validated CMMS software was designed around that type of use. GxPReady Suite™ provides controlled equipment records, user access controls, audit trails, electronic record functionality, and validation documentation intended to support qualification of the system. The platform is designed to minimize configuration and administrative overhead rather than requiring a company to build a large validation program around a heavily configurable enterprise system.

What Does a 503A Pharmacy Gain?

Even when a specific CGMP software-validation requirement does not apply, a validated system can provide useful assurance that:
  • Required equipment records are retained
  • Calibration and maintenance history can be reconstructed
  • Changes to records are traceable
  • User access is controlled
  • Critical information cannot be casually overwritten
  • System functions have been tested
  • Documentation exists showing that the software performs as intended
These capabilities can be useful during an inspection, internal review, investigation, or simply during routine operation. They can also reduce dependence on spreadsheets, uncontrolled shared files, paper records, or software whose performance for its intended use has never been formally evaluated.

What About 503B Outsourcing Facilities?

For 503B outsourcing facilities, the regulatory situation is different. FDA states that outsourcing facilities are subject to CGMP requirements. As a result, computerized systems that perform CGMP functions should be evaluated and controlled within the facility's pharmaceutical quality system. That does not mean every computerized system requires the same level of validation. A risk-based approach should still be used. A system maintaining critical GMP records or supporting significant quality functions deserves substantially more attention than software performing a minor administrative task. But for 503B facilities, computerized-system validation fits much more directly within the CGMP framework than it does for a 503A pharmacy.

The Practical Question for a 503A Pharmacy

For a 503A pharmacy, the decision may not come down to whether FDA specifically requires a particular piece of software to be validated. A better question may be:
If I can use a validated system without significantly increasing my cost, complexity, or administrative workload, why would I choose an uncontrolled alternative?
For equipment calibration, maintenance, and qualification records, a straightforward validated system can provide an additional layer of assurance while still remaining practical for a smaller operation. That is the niche GxPReady Suite™ is intended to fill: providing the controls and documentation useful in regulated environments without requiring the infrastructure normally associated with a large pharmaceutical computerized system.

503A, 503B, and GMP: The Bottom Line

A 503A compounding pharmacy that meets the applicable requirements of Section 503A may qualify for exemption from federal CGMP requirements. A 503B outsourcing facility does not receive that CGMP exemption and is subject to FDA CGMP requirements. But exemption from CGMP does not make reliable records, controlled access, traceability, or documented software performance undesirable. For a 503A operation, validated software may therefore be less about satisfying a blanket regulatory requirement and more about obtaining stronger control over important operational records. And when that control can be obtained without significantly increasing cost or complexity, validated software may simply be the more practical choice.

Need a Practical Validated System?

GxPReady Suite™ provides controlled calibration, maintenance, and equipment qualification records without the cost and administrative overhead normally associated with large enterprise systems. See How GxPReady Suite™ Works
If you operate a 503A compounding pharmacy, you may not be required to use validated software in the same way as a pharmaceutical manufacturer or a 503B outsourcing facility. But that does not necessarily mean that non-validated software is the better choice.When validated software is available at a similar cost, is straightforward to implement, and does not require a large validation effort to maintain, it can provide an additional level of control and documentation without creating the burden that many smaller organizations associate with pharmaceutical computerized systems. Understanding why starts with the difference between 503A, 503B, and traditional pharmaceutical manufacturing.

What Is a 503A Compounding Pharmacy?

Section 503A of the Federal Food, Drug, and Cosmetic Act applies primarily to traditional pharmacy compounding performed by licensed pharmacists in state-licensed pharmacies or federal facilities, or by licensed physicians. When the requirements of Section 503A are met, compounded drug products may qualify for exemptions from several provisions of federal drug law, including the current Good Manufacturing Practice, or CGMP, requirements that apply to conventional pharmaceutical manufacturers. FDA explains the applicable requirements for 503A and 503B compounders in its overview of FD&C Act provisions that apply to human drug compounding . This is an important distinction. A 503A pharmacy is not simply a smaller pharmaceutical manufacturing facility operating under the same regulatory framework. 503A compounding generally centers on patient-specific prescriptions and remains subject to other applicable federal requirements as well as state pharmacy laws and standards.

How Is 503B Different?

Section 503B created a separate category known as an outsourcing facility. Unlike compounders operating under Section 503A, 503B outsourcing facilities are subject to CGMP requirements. They are also registered with FDA, inspected according to a risk-based schedule, and subject to additional requirements such as product reporting and adverse-event reporting. A 503B facility may also compound products without first receiving a patient-specific prescription, such as products intended for office stock. FDA provides additional information on these requirements in its Human Drug Compounding Laws resource.

503A, 503B, and Conventional Pharmaceutical Manufacturing

  • 503A: May qualify for exemption from federal CGMP requirements when all applicable conditions of Section 503A are met.
  • 503B: Subject to CGMP requirements.
  • Conventional pharmaceutical manufacturing: Subject to the applicable CGMP requirements for drug manufacturing.
That difference matters when computerized systems are selected and controlled.

Does That Mean a 503A Pharmacy Does Not Need Validated Software?

Not necessarily. The fact that a 503A pharmacy may qualify for exemption from CGMP requirements does not mean that software used to support important operations should be uncontrolled or unreliable. Consider computerized systems used to manage activities such as:
  • Equipment calibration
  • Preventive maintenance
  • Equipment qualification
  • Facility and equipment records
  • Controlled equipment histories
  • User access
  • Changes to critical records
For these applications, the practical question may be less:
“Am I explicitly required to validate this software?”
and more:
“How do I know this system reliably performs the functions I depend on?”
That is the basic purpose of software validation: documented evidence that a computerized system performs its intended functions appropriately and consistently for its intended use.

Why Smaller Facilities Often Avoid Validated Systems

The term validated software can sound expensive and complicated. For organizations familiar with large pharmaceutical implementations, validation may bring to mind:
  • Detailed requirements specifications
  • Multiple validation protocols
  • Extensive change control
  • Outside consultants
  • Months of implementation work
  • Large IT departments
  • Expensive enterprise software
For a smaller compounding pharmacy, that level of infrastructure may make little practical or economic sense. But validated software does not inherently require that level of overhead. The amount of validation effort should be appropriate to the complexity, intended use, and risk of the system.

A More Practical Approach to Validated Software

For relatively straightforward applications such as equipment calibration, maintenance, and qualification tracking, the system itself does not have to be particularly complicated. That creates an opportunity to obtain many of the benefits of a controlled, validated system without creating an enterprise-scale validation program. GxPReady® validated CMMS software was designed around that type of use. GxPReady provides controlled equipment records, user access controls, audit trails, electronic record functionality, and validation documentation intended to support qualification of the system. The platform is designed to minimize configuration and administrative overhead rather than requiring a company to build a large validation program around a heavily configurable enterprise system.

What Does a 503A Pharmacy Gain?

Even when a specific CGMP software-validation requirement does not apply, a validated system can provide useful assurance that:
  • Required equipment records are retained
  • Calibration and maintenance history can be reconstructed
  • Changes to records are traceable
  • User access is controlled
  • Critical information cannot be casually overwritten
  • System functions have been tested
  • Documentation exists showing that the software performs as intended
These capabilities can be useful during an inspection, internal review, investigation, or simply during routine operation. They can also reduce dependence on spreadsheets, uncontrolled shared files, paper records, or software whose performance for its intended use has never been formally evaluated.

What About 503B Outsourcing Facilities?

For 503B outsourcing facilities, the regulatory situation is different. FDA states that outsourcing facilities are subject to CGMP requirements. As a result, computerized systems that perform CGMP functions should be evaluated and controlled within the facility's pharmaceutical quality system. That does not mean every computerized system requires the same level of validation. A risk-based approach should still be used. A system maintaining critical GMP records or supporting significant quality functions deserves substantially more attention than software performing a minor administrative task. But for 503B facilities, computerized-system validation fits much more directly within the CGMP framework than it does for a 503A pharmacy.

The Practical Question for a 503A Pharmacy

For a 503A pharmacy, the decision may not come down to whether FDA specifically requires a particular piece of software to be validated. A better question may be:
If I can use a validated system without significantly increasing my cost, complexity, or administrative workload, why would I choose an uncontrolled alternative?
For equipment calibration, maintenance, and qualification records, a straightforward validated system can provide an additional layer of assurance while still remaining practical for a smaller operation. That is the niche GxPReady is intended to fill: providing the controls and documentation useful in regulated environments without requiring the infrastructure normally associated with a large pharmaceutical computerized system.

503A, 503B, and GMP: The Bottom Line

A 503A compounding pharmacy that meets the applicable requirements of Section 503A may qualify for exemption from federal CGMP requirements. A 503B outsourcing facility does not receive that CGMP exemption and is subject to FDA CGMP requirements. But exemption from CGMP does not make reliable records, controlled access, traceability, or documented software performance undesirable. For a 503A operation, validated software may therefore be less about satisfying a blanket regulatory requirement and more about obtaining stronger control over important operational records. And when that control can be obtained without significantly increasing cost or complexity, validated software may simply be the more practical choice.

Need a Practical Validated System?

GxPReady® provides controlled calibration, maintenance, and equipment qualification records without the cost and administrative overhead normally associated with large enterprise systems. See How GxPReady Works
Share the Post: